Clinical Trial Update: Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) [Phase 3]

View source ↗

Summary

Phase 3 AMADEUS trial comparing SR34006 against warfarin or acenocoumarol in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Acenocoumarol (Acenocoumarol)
• SR34006
• Warfarin (warfarin)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED